Literature DB >> 15767491

Revised indications for early treatment of retinopathy of prematurity.

James F Vander, J Arch McNamara, William Tasman, Gary C Brown.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15767491     DOI： 10.1001/archopht.123.3.406-b

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  9 in total

1.  The further refinement of ROP treatment. commentary on the early treatment of retinopathy of prematurity study: structural findings at 2 years of age.

Authors:  Alistair R Fielder; Andrew R Wilkinson
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

2.  The Early Treatment for Retinopathy of Prematurity Clinical Trial: presentation by subgroups versus analysis within subgroups.

Authors:  R J Hardy; W V Good; V Dobson; E A Palmer; B Tung; D L Phelps; M J Shapiro; W A J van Heuven
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

3.  Three-dimensional assessment of vascular and perivascular characteristics in subjects with retinopathy of prematurity.

Authors:  Ramiro S Maldonado; Eric Yuan; Du Tran-Viet; Adam L Rothman; Amy Y Tong; David K Wallace; Sharon F Freedman; Cynthia A Toth
Journal:  Ophthalmology       Date:  2014-01-21       Impact factor: 12.079

4.  Effect of two different doses of intravitreal bevacizumab with temporal retina-sparing laser photocoagulation for retinopathy of prematurity.

Authors:  A Young Choi; Hochan Cho; Yu Cheol Kim
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

5.  Foveal structure changes in infants treated with anti-VEGF therapy or laser therapy guided by optical coherence tomography angiography for retinopathy of prematurity.

Authors:  Xun Deng; Yong Cheng; Xue-Mei Zhu; Dan-Dan Linghu; Hua Xu; Jian-Hong Liang
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

6.  Combination of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity.

Authors:  Agata Mota; Angela Carneiro; Jorge Breda; Vitor Rosas; Augusto Magalhães; Renato Silva; Fernando Falcão-Reis
Journal:  Case Rep Ophthalmol       Date:  2012-04-30

7.  Authors' reply.

Authors:  Krishna A Rao; Purkayastha Jayashree; Hazarika Manali; Chaitra Raghuvamsi; Adith K S Mithun
Journal:  Indian J Ophthalmol       Date:  2014-09       Impact factor: 1.848

8.  HFOV vs CMV for neonates with moderate-to-severe perinatal onset acute respiratory distress syndrome (NARDS): a propensity score analysis.

Authors:  Kaizhen Liu; Long Chen; Jing Xiong; Shuqin Xie; Yuan Hu; Yuan Shi
Journal:  Eur J Pediatr       Date:  2021-02-27       Impact factor: 3.183

9.  Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment.

Authors:  Sadik Gorkem Cevik; Mediha Tok Cevik; Irfan Perente
Journal:  Beyoglu Eye J       Date:  2020-07-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.